Profile data is unavailable for this security.
About the company
CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.
- Revenue in USD (TTM)360.94bn
- Net income in USD7.32bn
- Incorporated1996
- Employees300.00k
- LocationCVS Health Corp1 Cvs DrWOONSOCKET 02895-6146United StatesUSA
- Phone+1 (401) 765-1500
- Fax+1 (302) 655-5049
- Websitehttps://cvshealth.com/
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 110.38m | 8.77% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 57.79m | 4.59% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 55.00m | 4.37% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 43.78m | 3.48% |
| Dodge & Coxas of 31 Mar 2024 | 41.01m | 3.26% |
| Capital Research & Management Co. (International Investors)as of 31 Mar 2024 | 37.92m | 3.01% |
| Geode Capital Management LLCas of 31 Mar 2024 | 25.38m | 2.02% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 21.97m | 1.75% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 18.44m | 1.47% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 13.83m | 1.10% |
